Bath & Body Works (BBWI) Projected to Post Quarterly Earnings on Thursday

Bath & Body Works (NYSE:BBWI) is projected to announce its Q3 2026 results before the market opens on Thursday, November 20th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $1.6405 billion for the quarter. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS.Investors can check the company’s upcoming Q3 2026 earningsummary page for the latest details on the call scheduled for Thursday, November 20, 2025 at 8:30 AM ET.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same period in the previous year, the business posted $0.37 earnings per share. The firm’s quarterly revenue was down .8% compared to the same quarter last year. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Trading Up 1.8%

Shares of BBWI stock opened at $22.36 on Thursday. Bath & Body Works has a 12 month low of $21.71 and a 12 month high of $41.87. The stock has a market cap of $4.61 billion, a P/E ratio of 6.63, a P/E/G ratio of 0.86 and a beta of 1.53. The company has a 50 day simple moving average of $25.84 and a two-hundred day simple moving average of $28.66.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio is 23.74%.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors and hedge funds have recently modified their holdings of the stock. Balyasny Asset Management L.P. lifted its holdings in shares of Bath & Body Works by 63.0% in the second quarter. Balyasny Asset Management L.P. now owns 1,120,926 shares of the company’s stock worth $33,583,000 after buying an additional 433,309 shares in the last quarter. Alliancebernstein L.P. grew its stake in Bath & Body Works by 5.8% during the second quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after acquiring an additional 315,738 shares in the last quarter. Amundi increased its holdings in Bath & Body Works by 134.1% in the 2nd quarter. Amundi now owns 409,496 shares of the company’s stock valued at $13,423,000 after acquiring an additional 234,545 shares during the last quarter. AQR Capital Management LLC lifted its stake in Bath & Body Works by 5.3% in the 2nd quarter. AQR Capital Management LLC now owns 4,203,326 shares of the company’s stock worth $125,322,000 after purchasing an additional 210,153 shares in the last quarter. Finally, Makaira Partners LLC lifted its stake in Bath & Body Works by 12.2% in the 2nd quarter. Makaira Partners LLC now owns 1,839,039 shares of the company’s stock worth $55,098,000 after purchasing an additional 200,000 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on BBWI shares. Morgan Stanley lifted their target price on Bath & Body Works from $40.00 to $43.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $26.00 price objective on shares of Bath & Body Works in a research note on Monday, October 6th. Wells Fargo & Company cut their price objective on Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, October 27th. Jefferies Financial Group decreased their target price on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research note on Monday, October 13th. Finally, UBS Group lowered their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Ten research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Bath & Body Works currently has an average rating of “Moderate Buy” and an average price target of $38.18.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.